Contrary to all previously-discussed lincRNAs, RNA-sequencing data from breast cancer patients revealed that Linc01087 is significantly downregulated in patients with triple negative breast cancer (TNBC), who have worse prognosis and high risk of recurrence and metastasis, compared to samples from cancer-free women while it is upregulated in patients with luminal breast cancer, who usually have better prognosis [65,66]. Here, LINC01087 is linked to breast cancer.